Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study
Year: 2025
Type: article
Study design: Observational Study
Source: Lung Cancer
Authors: Igor Gomez-Randulfe, Federico Monaca, Ornella Cantale, Maria Lucia Reale, Loredana Mrak, Lodovica Zullo, Sofia Silva Diaz, Marta Zaragoza Bueno, Marya Alejandra Maridueña Moreno, Charlotte Davis, Samantha Cox, Daniel Lee, Riyaz Shah, Tom Geldart, Javier Baena, Jose Carlos Benitez, M.A. Rosario Garcia Campelo, Jordi Remon, David Planchard, Domenico Galetta, Marcello Tiseo, Diego Cortinovis, Giulio Metro, Emilio Bria, Francesco Passiglia, Silvia Novello, Raffaele Califano
Institutions: The Christie Hospital, The Christie NHS Foundation Trust, Agostino Gemelli University Polyclinic, Ospedale San Luigi Gonzaga, University of Turin, Ospedale Vito Fazzi, University Clinic of Pulmonary and Allergic Diseases Golnik, Institut Gustave Roussy, Fondation Gustave Roussy, Universidade da Coruña, Hospital Clínico Universitario Virgen de la Victoria, Hospital Universitario 12 De Octubre, University Hospitals Dorset NHS Foundation Trust, Velindre NHS Trust, Leeds Teaching Hospitals NHS Trust, Maidstone and Tunbridge Wells NHS Trust, Istituto Tumori Bari, Azienda Ospedaliera San Gerardo, University of Milano-Bicocca, University of Manchester
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4415313224